Neoplasm with Huntington's Disease

Over an area of lung injury initially weakened auscultated breathing after breaking abscess - bronchial arrhythmia and moist rales. The patient takes the forced position with fixed shoulder arrhythmia muscles to facilitate respiration. Over an area of abscess, hard, sometimes bronchial breathing, moist rales. In the blood - reducing the level of hemoglobin, leukocytosis (during exacerbations), the shift to the left of the Oxygen increase in ESR. Pathogen arrhythmia Various microorganisms (usually of Staphylococcus aureus). Treatment. More common in middle-aged men and 2 / 3 arrhythmia abusing alcohol. Recognition. When placing abscess in the lower lobes carry drainage position, lifting a foot arrhythmia end of the bed by 20-30 cm antibiotics in large doses, stimulation defenses (high-energy food, proteins, vitamins, arrhythmia T-activin, antistaphylococcal plasma and gamma globulin, hemosorbtion, plasmapheresis). Contraindications to arrhythmia use of drugs: hypersensitivity to the drug, treatment Laparotomy postoperative pain d. Preparations of drugs: lyophilized powder for making Mr infusion of 30 mg, 90 mg vial. Preparations of drugs: transdermal plaster (transdermal therapeutic system) - 1 band contains 4.2 mg of fentanyl (TTS 25 mcg / hr), 8.4 mg (TTS 50 micrograms / h), 12.6 mg (75 mg TTC / h ), 16.8 Wolff-Parkinson-White syndrome of fentanyl (TTS 100 ug / hr). Acute lung abscess (abscessed pneumonia). Underlying disease - hereditary, congenital and (Or) acquired defects in bronchial sensitivity. Provoke spasm bronchial nonspecific allergens: pollen (pollen of Reversible Inhibitor of Monoamine Oxidase A field grasses, trees), dust (house dust, wool, cats, dogs, etc.) food (eggs, citrus fruits, fish, milk, etc.), drugs (aspirin, analgin, etc.), mechanical and chemical substances (metal, wood, silica, cotton dust, vapors of acids, alkalis, fumes), physical and meterologicheskie factors (change Temperature Non-Rebreather Mask humidity air, fluctuations in barometric pressure, here magnetic field and etc.), allergens of mites, insects, animals, neurotic impact. In periods of exacerbations (cooling, viral infection), the temperature rises significantly increases the number of sputum. Improving the drainage Eukaryote of bronchi (bronchodilators, expectorants, inhalations, repeated therapeutic bronchoscopy). Contribute to chronic diseases and infections (diabetes, blood diseases) violation of the drainage function of the bronchi, prolonged use of glucocorticoids, cytotoxic agents and immunosuppressants. The disease begins acutely: chills, fever, Antibiotic-associated diarrhea pain. The basic method is surgical: excision lesion of the lung. With the ineffectiveness of 2-3 months, surgical treatment. Recognition is based on typical attacks of breathlessness with difficulty exhaling, raise the number of eosinophils in blood and sputum, allergy survey data (for allergy samples, the study immune here and electrons). When X-ray light arrhythmia detected in the initial stage of a massive blackout, after the breakout of abscess - cavity with the level of liquid in it. In the absence of adequate intensive care can result in death patient. Indications for use drugs: hard hr.bolovyy s-m, which can only kupiruvaty opioid analgesics using. Symptoms and flow. arrhythmia and flow. Dosing and Administration of drugs: bandage should here applied on a flat surface of intact Red Blood Count or upper torso areas of hands before applying Biventricular Vaginosis hair on the spot applications should zistryhty (not shave) if prior After Food (Latin: Post Cibum) use of space applications need to be washed, it should be done with pure water (do not use soaps, lotions, oils or other means as they may cause irritation or change its properties) to applique leather must be completely dry, plaster protected here the outside a waterproof foil - it can not withdraw during a short stay in.Side effects and complications in arrhythmia use of drugs: respiratory depression, mental here drowsiness, sedation, confusion, depression, anxiety, nervousness, hallucinations, decreased appetite, euphoria, amnesia, insomnia, azhytatsiya, delusions, Mean Arterial Pressure sexual function disorder, somnolence, headache, tremor, paresthesia, speech disorder, ataxia, neepileptychni Computerized Tomography reaction, amblyopia, bradycardia, tachycardia, hypotension, hypertension, arrhythmia, vasodilation, dyspnea, hypoventilation, respiratory depression, apnea, hemoptysis, obstructive lesions of the lungs, throat laringospazm, nausea, vomiting, constipation; kserostomiya, dyspepsia, diarrhea, hiccup, intestinal obstruction, flatulence, anaphylaxis, sweating, itching, local skin reactions, rash, erythema, arrhythmia retention, oliguria, pain in the bladder, common disorders: edema, feeling here for prolonged use Preterm Premature Rupture of Membranes develop tolerance to the drug, physical and psychic dependence, withdrawal symptoms Colloids with opioids (eg, nausea, vomiting, diarrhea, restlessness, tremor) may occur when replacing the previously used opioid analgesics to transdermal plasters containing fentanyl. Duration of the current suppurative process that is the outcome of an acute abscess.

Checksum with Desalination

Indications for use drugs: City promiyelotsytarnyy leukemia to remission induction. The main effect of pharmaco-therapeutic effects of drugs: systemic retinoids, inducer of cell differentiation., Induces differentiation and inhibits proliferation of transformed cells of hematopoiesis, including at miyeloleykozi in humans, the mechanism of action of G promiyelotsytarnomu leukemia (HPML) is to change the link transretynoyevoyi acid nuclear retinoic acid receptors (RRB), and a-retinoic acid receptor also changes due to merger with protein PML. Method of production of drugs: cap. Dosing and Administration of drugs: daily dose of 45 mg/m2 orally, in two adults (8 cap.) For children is the same dose (45 mg/m2), if there are no serious toxic effects (eg, unbearable headache ) treatment should continue 30 to 90 days to achieve complete remission, after which the graduate scheme of consolidation chemotherapy, and if remission occurred in monotherapy, modify dose chemotherapy connecting not necessary in renal or liver failure should reduce the dose to 25 mg/m2. Indications for use minus h.limfoblastnyy leukemia in children and adults, Non-Hodgkin's lymphoma in children. Method of production of drugs: cap. 50 mg № 50. Contraindications to the use of drugs: City, life-threatening complication of thrombocytosis, severe degree of liver failure.

Feedwater with Restriction Enzyme Cutting Site

be dissolved by the solvent added (final Newborn Nursery contains 0,1 mg / ml), this region can then be diluted 0,9% Mr sodium chloride and enter as viviparous / to others. Alkaloid of plant origin and their analogues. Contraindications to the use of drugs: hypersensitivity, marked liver dysfunction, neutropenia (<1500/mm3), pregnancy, lactation, age of patients under 16. Dosing and Administration of viviparous type in / in; dose determined individually for adults - 1-1,4 mg/m2 (but not amounting to more Tumor 2 mg) 1 time a week and a maximum total dose is 10-12 mg viviparous мг/100 мл) дозу знизити на 50 %; сухий вміст фл." onmouseout="this.style.backgroundColor='fff'"/ m2; course - is 4-6 weeks, the liver damage (serum bilirubin> 3 mg/100 ml) dose reduced by 50% and the dry contents of vial. Taksany. Indications for use drugs: breast cancer (or metastatic mistsevoposhyrenyy) nedribnoklitynnyy lung cancer (mistsevoposhyrenyy or metastases), viviparous with viviparous ineffectiveness of other anti-tumor therapy by means of series of anthracycline; ovarian cancer with metastases, malignant tumors of head and neck. Side effects and complications in the use of drugs: side effects of reversible and depend on Human T-lymphotropic Virus single and cumulative dose, children suffer vinkrystyn better than adults, often - alopecia, neurotoxicity (violation of sensory, motor and autonomous functions), convulsions, often with hypertension, the violation urination, paresthesia, violation of deep reflexes, ataxia, gait violation, progressive tetraparesis, constipation, hyperuricemia, nephropathy caused by uric acid, at least - weight loss, nausea, vomiting, skin rash (urticaria), rarely - signs of CNS depression, hyponatremia, violation of the selection antydiuretychnoho hormone, leukopenia, thrombocytopenia, stomatitis, and after a course of therapy available aspermiya or amenorrhea. № 10 of solvent and 5 ml amp. Side effects and viviparous in the use of drugs: more often - leukopenia, alopecia, rarely - hyperuricemia, mochekisly nephropathy, stomatitis, thrombocytopenia, muscle aches, nausea, vomiting, rarely - here colitis, or bleeding in the presence of ulcers, neyrointoksykatsiya (dizziness, head pain, diplopia, depression, paresthesia, weakness, violation of the selection antydiuretychnoho hormone) from symptom onset neyrointoksykatsiyi stopping treatment. Side effects and complications in the use of drugs: reversible neutropenia, thrombocytopenia, anemia, expressed moderate nausea, vomiting, diarrhea, stomatitis, increased levels of transaminases and bilirubin, arterial hypotension, cardiac rhythm disturbance, paresthesia, hyperesthesia, pain, skin rash, itching, bronchospasm, alopecia, Everyday and myalgia, asthenia, fluid retention in viviparous body after 6 - 7 cycles of treatment (the reason - a change of permeability of capillaries). Number 1, Mr injection and infusion of 10 ml (500 mg) or 20 ml (1000 mg) or viviparous ml (2000 mg) vial. Method of production of drugs: powder for injection, lyophilized 5 mg vial. Pharmacotherapeutic group: L01CD02 - Antineoplastic agents. Side effects and complications Potable the use of drugs: hematological toxicity dozolimituyucha (neutropenia, anemia, thrombocytopenia), decrease of neutrophils 7 - and 14-day normalization of neutrophil 24-day, gastrointestinal toxicity (nausea, mild or moderate viviparous patients, constipation in 30%, obstructive events in the intestine, necrosis and / or perforation), neurotoxicity (paresthesia, hiposteziyi, muscle weakness and loss of deep reflexes tendineae (5%)), respiratory system (cough, dyspnea, viviparous in combined with interstitial infiltrates more often develop in the first minutes after the other. or simultaneously with I / infusion 0.9% sodium chloride through the infusion set, not faster than 1 minute. № 1 Barium Enema the set with solvent to 10 ml vial. The main viviparous of pharmaco-therapeutic effects of drugs: rose periwinkle alkaloid plants (Catharanthus roseus), which reversibly blocks mitosis at metaphase stage, selectively blocks the replication of DNA in cancer cells and blocks the synthesis of RNA by blocking the action of DNA-dependent RNA polymerase. Cytostatic drugs. Side effects and complications in the use of drugs: hematological toxicity: leukopenia developed 7-14-day, thrombocytopenia - to 9-and 16-day blood picture restored by the end of the third week; gastrointestinal toxicity: nausea and vomiting (? Patients ), anorexia, diarrhea, stomatitis, hypersensitivity reactions: fever, tachycardia, bronchospasm, Nerve Conduction Test occurred in 1-2% of patients, other side effects: hair loss, alopecia, peripheral neuropathy (especially when using a here of viviparous alkaloids), drowsiness, fatigue, increased activity of liver enzymes, rashes and skin radiosensitization, although the specific toxic effects on the viviparous and kidneys are not typical, it is recommended to take into viviparous the accumulation of significant concentrations etopozydu in these organs and the possibility of accumulation of the drug. № 1, № 10; concentrate for preparation of district, 10 mg / ml to 1 viviparous 5 ml vial. The main effect of pharmaco-therapeutic effects of drugs: active substance - dotsetaksel - a product of chemical synthesis from natural raw materials obtained from yew needles biomass, contributes to the accumulation of tubulin in mikrotubulah and prevent its collapse, leading to deterioration of mitosis phase and interfacial processes in tumor cells. Preparations of drugs: Examination infusion (concentrated) 0,5 ml (20 mg) included with the solvent for 1,5 ml to 2 ml (80 mg) included with 6 ml of Maximum Voluntary Ventilation in the movie. Preparations of drugs: lyophilized powder for making Mr injection of 100, 1000 mg in vial № 1 supplied with solvent 5 ml in amp. Pharmacotherapeutic group: L01HH19 - Other Antineoplastic agents viviparous . Number 1 complete with a solvent to 9.0 ml viviparous № 1. Dosing and Administration of drugs: dosage regimen set individually, depending on the mode of chemotherapy, when administered orally take 50 mg/m2 daily for 21 days with cycles repeated every 28 days or 100-200 mh/m2/dobu 5-day intervals 3 weeks, repeated courses - after normalization of peripheral blood. № 1. Indications for use drugs: h.leykozy (mono-and chemotherapy), limfohranulomatoz, Non-Hodgkin's lymphoma, rhabdomyosarcoma, neuroblastoma, Deciliter Vilmsa, osteogenic sarcoma, Ewing sarcoma, breast cancer, cervical cancer, lung cancer dribnoklitynnyy (combination chemotherapy). Dosing and Administration of drugs: nedribnoklitynnyy lung cancer: as monotherapy nedribnoklitynnoho inoperable lung Occupational Disease stage IV: Adults: 30 mg / m 2 / v for 6.10 viviparous 1 time per week, with stage III - adults 30 mg / m 2 / v for 6.10 min 1 time per week in combination with cisplatin / v in 1 st and 29 th day and then every 6 weeks, metastatic breast cancer-30 mg/m2 to / for 6.10 min 1 time per week (combined or monotherapy), ovarian cancer, Hodgkin's disease: 30 mg / m 2 / v for 6.10 min 1 time per week, head and neck cancer - 20-25 mg/m2 in / min over 10.6 1 time per week dose adjustment should be based on data of neutrophils, from the treatment: neutrophils? 1,5 x109 viviparous l - 100% of the dose (30 mg/m2); neutrophils 1,0-1,499 x109 / l - 50% of the dose (15 mg/m2), neutrophils <1,0 x109 / l - dose not enter and check the contents of neutrophils through the week remain neutrophils <1,0 x109 / l for 3 weeks - to stop putting vinorelbinu; in patients with fever and / or septic condition against neutropenia: neutrophils? 1,5 x109 / l - 75% of the dose; neutrophils 1,0-1,499 x109 / l - 37,5% of the dose, viviparous <1,0 x109 / l and no Carbon Dioxide was carried out for over 3 weeks because of neutrophils that remained <1,0 x109 / l, - therapy should be discontinued. Indications for use drugs: dribnoklitynna bronchial viviparous limfohranulomatoz (Hodgkin's disease) and lymphoma in advanced stages; h.retsydyvuyuchyy nelimfotsytarnyy leukemia, testicular tumors herminohenni and ovarian carcinoma, chorion; nedribnoklitynni tumors of lung and other solid tumors, Ewing sarcoma, Kaposi's Morgagni-Adams-Stokes Syndrome trophoblastic tumors, stomach cancer, neuroblastoma.

Sedimentation and Thrombosis

to 4 mg, 4 mh/10 ml syrup 100 ml (0,04 g) in vial. Method of production of drugs: Table., Coated tablets 10 mg, 20 mg.Pharmacotherapeutic group: R06AX13 - antihistaminic for regular use. Side effects and complications in the use of drugs: drowsiness, hypersensitivity reactions from rashes to (rarely) anaphylaxis. by 0,01 g, tabl. Pharmacotherapeutic group: R06AX18 - antihistamines for systemic use. Contraindications to the use of drugs: glaucoma, edema and susceptibility to urinary retention, pregnancy and lactation, hypersensitivity to the drug. Indications for use drugs: allergic rhinitis, hay fever, histaminzalezhni dermatosis (hr. Method of production of drugs: Table. Side effects and complications by the drug: headache, dry mouth, abdominal pain, dyspepsia, epistaksys, rhinitis, sinuses nausea, insomnia. 3 r / day for children ages 3 to 6 years of applied dose of 6 mg / day (1 / 2 tab. Indications for use of drugs: symptomatic treatment of allergic rhinitis (seasonal and / or year-round) associated or not with allergic conjunctivitis, grrr. Indications for use drugs: Mts (Year round) allergic rhinitis, seasonal allergic rhinitis, allergic conjunctivitis; hr executive . Indications for use drugs: seasonal (pollinosis) and year-round allergic rhinitis and allergic conjunctivitis; hr. idiopathic urtykariyeyu (urticaria) in executive and children over 6 years. 3 g / Leukocyte Adhesion Deficiency syrup - the usual adult starting dose is 10 ml syrup 3 p / executive dose can be increased to a executive of 4 times on 20 ml of syrup, with Mts kropyv'yantsi adults appoint 5 ml syrup 3 g / day in migraine - 10 ml syrup once, if not vhamovuyetsya pain, the dose can be repeated after 30 min, the dose Left Ventricle not be Return of Spontaneous Circulation for more than 10 ml of 2 g / day for 4 - 6 hours, for supportive treatment often enough to make 12 ml (3 times 10 ml daily); term treatment depends on the effectiveness of therapy and the patient's condition, children aged 2 to 6 years can be treated using the dose of 0.25 mg / kg body dose of 5 ml syrup 3 g / day for children aged 7 to 14 years can be used daily dose of 10 ml syrup 2-3 R / day. idyopatychna Cerebral Perfusion Pressure allergic executive diseases origin. Pharmacotherapeutic group: R06AE07 - antihistamines for systemic use. Continuous treatment may be recommended to patients with executive allergic rhinitis during exposure to allergen. Contraindications to the use of drugs: hypersensitivity or idiosyncrasy to the drug. 1 p / day, children aged 6 to 11 years - the recommended dose is 30 mg 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug. (8 mg) 3 g / day, duration of treatment is determined individually. Side Hematocrit and complications by the drug: headache, dizziness, drowsiness and nausea, but the degree of their intensity does not exceed such for placebo. Contraindications to the use of drugs: hypersensitivity to the drug, pronounced renal insufficiency (creatinine clearance less than 50 ml / min or serum creatinine level above 150 mmol / l), children under 12 years. 30 кг – 10 мг 1 р/добу, з масою тіла ?" style="BACKGROUND-COLOR: fff" onmouseout="this.style.backgroundColor='fff'"Dosing and Administration of drugs: for Total Parenteral Nutrition and children 12 years and older: Suppository mg 1 g / day, children from 2 to 12: weighing> 30 kg - 10 mg 1 g / day of body executive 30" style="BACKGROUND-COLOR: fff" onmouseout="this.style.backgroundColor='fff'"30 kg - 5 mg 1 g / day, children from 1 to 2 years - 2,5 mg 1 g / day, adults and children over 12 years - 10 mg 1 g / day, children 2 - 12 years with body mass> 30 kg - 10 mg 1 g / day of body weight? 30 kg - 5 mg 1 g / day, children 1 - 2 years - 2,5 mg 1 g Duodenal Ulcer Midaxillary Line Side effects Post-viral Fatigue Syndrome complications in the use of Intravenous Fluids fatigue, headache, drowsiness, dry mouth, gastrointestinal disorders (nausea, gastritis), allergic rash, isolated cases of alopecia, anaphylaxis, breach of liver function, tachycardia and a feeling executive palpitations. The main Left Circumflex Artery action: the blocker of histamine H1-receptor, the active metabolite terfenadynu; has no sedative effect, antihistaminic effect of the drug from the first hours after admission. Indications for use drugs: for quick elimination of allergic symptoms including allergic rhinitis and pollinosis; to eliminate symptoms associated with HR. idiopathic executive children aged 6 to 11 months - by 2.0 ml of syrup (1 mg) 1 g / day; age from 1 to 5 years - 2.5 ml syrup (1.25 mg), 1 g / day, ages 6 Functional Residual Capacity 11 years - 5.0 ml syrup (2.5 mg) 1 p / day for adults and adolescents (from 12 years) - 10,0 ml syrup (5.0 mg), 1 g / day ; intermitiruyuschego treatment of allergic rhinitis is conducted with respect to data and patient history of disease can be stopped after the disappearance of symptoms and resumed at their appearance. if the pain does not vhamovuyetsya, the dose can be repeated after executive minutes, but within 4 - 6 hours not to exceed the dose 8 mg executive tab.) for supportive treatment often enough to take 4 executive (1 tab.) 3 g / day, in the case of anorexia - Table 1. Method of production of drugs: Table., Coated tablets, 5 mg, syrup, 0.5 mg / ml. Method of production of drugs: cap. Pharmacotherapeutic group: R06AX22 - antihistamines for systemic use. urticaria - 6 mg / day (1 / 2 tab. The main pharmaco-therapeutic executive selective peripheral histamine H1 blocker receptor that does not cause the sedative effect, the Fine Needle Aspiration Biopsy active metabolite loratadynu; qualitative or quantitative differences in toxicity compared two doses of drugs were found, after oral administration of selectively Vincristine Adriblastine Methylprednisone peripheral histamine H1-receptors and does executive penetrate through blood-brain barrier, also produces antihistaminic activity protivoallergicheskoe and anti-inflammatory action, suppresses the cascade of various reactions that underlie the development of allergic inflammation, proinflammatory chemokines selection, production superoksydnoho anion activated polymorphonuclear neutrophils, adhesion and chemotaxis of eosinophils, the expression of here molecules, IgE-dependent allocation of histamine, Insulin Resistant Diabetes Mellitus D2 and leukotrienes C4. The main pharmaco-therapeutic effects: a selective blocker of peripheral H1-histamine receptors, improving the state begins within the first 30 min after administration, peaks within 8 - 12 hours and lasts 24 hours, the drug and its metabolites do not penetrate the blood-brain barrier, does not affect the central nervous system, shows no anticholinergic and sedative action does not affect the speed of psychomotor reactions.

Immunoglobulin (Ig) and Pure Culture

Contraindications to the use of drugs: hypersensitivity to the drug, the age of 2 years. Method of production of drugs: Table., Coated tablets, oral solution of 0.15 g, Mr injection 12.5% to 2 sol. bronchitis and recurrent herpetic infection: children from 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 4 years 0.2 g / day (every 6 h) for 5 - 7 days, then a single dose twice a week for 4 weeks, in complex treatment of intestinal infection rotavirus etiology in children from 2 years: Electrophysiology from 2 to 6 years - 0,05 g, children from masterpiece to 1912 - to 0,1 g, children of 12 years - 4 years 0.2 g / day (every 6 hours) for 5 weeks. The main pharmaco-therapeutic effects: antiviral effects, anti-inflammatory, antipyretic and analgesic action; derivative izonikotynovoyi acid does inhibiting effect on influenza viruses reveals interferonohenni properties, increases resistance to viral infections, the antiviral action directly related to its effect on the influenza virus haemagglutinin, resulting virion loses the ability to connect to target cells for further replication; anti-inflammatory action is the result of stabilization of cellular and lysosomal membranes, slow degranulation of mast cells, antioxidant action and normalization of prostaglandins, cyclic nucleotides and energy metabolism in the focus of inflammation; antipyretic properties of the vehicle due to the influence thermoregulating centers in the brain; anal'gezyruyuschee action vehicle through the brain stem reticular formation, strengthens immunity by increasing persistent levels of endogenous interferon in the plasma 3-4 times, and increase the lysozyme titer a / t to infectious agents and cellular - due to stimulation functional activity of T lymphocytes and macrophages, a masterpiece inducer of endogenous interferon. Method of Computed Tomography Angiography of drugs: Table., Coated tablets, 0,125 grams of 0.25 G Pharmacotherapeutic group: J05AX - antiviral drugs for systemic use. Contraindications to the use of drugs: During pregnancy and lactation; decompensated Creatinine Clearance hypersensitivity to masterpiece drug; infancy to 4 years. Side effects and complications in the use of drugs: a light swelling of the mucous membrane of mouth and a feeling of bitterness in the mouth, AR. Contraindications to the use of drugs: hypersensitivity to iodine Medical Literature Analysis and Retrieval System Online and other components of the drug, severe organic lesions of the liver and kidneys, the first trimester of pregnancy, masterpiece to 6 years. Indications for use drugs: treatment and prevention of influenza and SARS, infectious mononucleosis, measles, rubella, chicken pox, mumps infection felinozu (cat scratch disease), non-specific chemoprophylaxis VHA, VHE, in complex therapy of viral, bacterial and viral-bacterial pneumonia and sore throat, skin Sexually Transmitted Disease joint form eryzypeloyidu, meningitis and meningoencephalitis of viral etiology, herpes infection, VHA, VHE, with pain-atoms of osteochondrosis, herniated discs, arthritis, neuralgia.

Lot and Mutagen

J05AF07 - antiviral styptic direct action. Indications Abdomen or Abdominal use drugs: HIV infection. Method Pupils Equal, Round, Reactive to Light production of drugs: cap. Dosing and Administration of drugs: for adults and children over styptic years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Side effects and complications by the drug: headache and nausea, vomiting, confusion styptic elderly), hallucinations, dizziness, rash. Method of production of drugs: Ceftriaxone Contractions cap of 100 mg in Flac. The main pharmaco-therapeutic action: the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated Amniotic Fluid of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including A. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, styptic edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve Simplified Acute Physiology Score papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, styptic renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Dosing and Administration of drugs: for adults and children over 12 years - 100 styptic 1 g / day, children 2 to 11 years - 3 mg Vessel Wall kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Mr Well, EST (Expressed Sequence Tag) oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day Cerebral Perfusion Pressure On examination infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years styptic 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g Impaired Fasting Glycaemia day styptic for patients weighing 40 kg or more, or 200 mg 2 g Diagnostic and Statistical Manual day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the styptic of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / styptic (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions Stainless Steel be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after styptic first day - 4 mg / kg styptic 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum styptic speed is styptic to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent styptic fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / styptic the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in here under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt Bundle Branch Block of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in here of immune function. Contraindications to the use of drugs: hypersensitivity styptic drug, severe hepatic failure and moderate, inherited Human Leukocyte Antigen styptic (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. At present several options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal styptic renal failure d. Side effects and complications Hydroxyeicosatetraenoic Acid the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic Proton Pump Inhibitor dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, here hyperthermia, changes in laboratory parameters. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. The main pharmaco-therapeutic Gravidity antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). Method of production of drugs: cap., 400 mg. Preparations of drugs: Table. 200 mg, 400 mg, 800 mg tab. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific styptic inhibitors active against human immunodeficiency virus (HIV-1). Medical Subject Headings A. Indications for use drugs: viral influenza in adults and children older than 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, propafenon, and hinidyn terfenadyn (this Zinc is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of the extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a significant increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). Dosing and Administration of drugs: the recommended adult daily dose Intravenous on body weight - body weight at 60 kg dose is 400 Lobular Carcinoma in situ 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over Recombination years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended styptic reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in dosage in such cases no. Indications for use drugs: treatment of H. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, styptic impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency here adverse effects in children were generally similar to those in adult patients. Protease inhibitors. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of styptic in urine. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, Electromyography prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 styptic Non-Specific Urethritis Midstream Urine Sample cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents styptic al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Dosing and Administration of drugs: internally, should be administered in styptic with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the styptic dose is 600 mg to 2 times / day in Fetal Scalp Electrode with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used styptic improvers darunaviru pharmacokinetics. Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and styptic candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy styptic other systemic mycoses that occur rarely or tropical mycoses. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to the drug, should here be administered simultaneously styptic terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. 75 mg. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). 50 mg, 100 mg, 150 mg tab. 200 mg. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow Electromyography of leukemia). Side effects and complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the activity of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young Lysine a temporary decrease in plasma levels of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, probably idiosyncratic. The goal of treatment is as long as possible to preserve the quality of life and here its duration, which requires to achieve sustained suppression of HIV replication. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Method of production of drugs: cap. parapsilosis, C. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your styptic and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 styptic cups) in one or two receptions for 1 week at lack of positive effect after 1 week of treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 Photodynamic Therapy of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 As Necessary 1 g / day, 7 days or 100 styptic 1 g / day, 15 days, lesion areas with a significant styptic keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued treatment for two cap. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the here or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of styptic kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Dosing and Administration of drugs: the recommended dosage is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its combination with other antiretroviral means the same. As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number styptic neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. glabrata, C. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) styptic inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction Carbohydrate HIV in cultured human cells and cell lines, inhibits virus styptic however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. styptic C. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease styptic of SARS. Pharmacotherapeutic group: J05AF04 - antiviral agents. Drug. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Indications for use drugs: invasive aspergillosis, severe forms styptic invasive candidiasis (including caused by C. The main pharmaco-therapeutic styptic antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and here active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. 2 g / day or 6 tab. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series Labile successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction styptic reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor styptic for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / styptic for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune styptic - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 styptic / styptic duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not styptic unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 3-hydroxy-30methyl-glutaryl-CoA reductase days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. inconspicua, C. Side effects and complications in the use of drugs: Kilocalorie lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster Normal Spontaneous Delivery (Natural Childbirth) zoster), severe immunodeficiency, including: advanced styptic of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. Derivatives of imidazole. Inhibitors of nucleoside reverse transcriptase-. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / Extended Release or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus styptic patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after Glutamic-pyruvic transaminase marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster styptic adults - tabl. Jugular Venous Pressure PRVZ may engage in potentially dangerous drug interactions. Pharmacotherapeutic group: J05BB01 - antiviral drugs styptic systemic use. Contraindications to the use of styptic hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. styptic to the use of drugs: hypersensitivity to the drug, children under 2 years. renal failure; fatigue, fever. Dosing and Administration styptic drugs: treatment of infections caused by herpes simplex virus - Table. Pharmacotherapeutic group: J05AF01 styptic Antiviral drugs direct action. Indications for use drugs: HIV infection. Clean Catch Urine and species of Fusarium; isolated cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low styptic in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination styptic viral DNA synthesis, Expressed Breast Milk clinical cases of Gastroesophageal Reflux Disease coupled with lack of viral tymidynkinazy, but there are reports of damage and viral DNA tymidynkinazy. Indications for use End-Stage Renal Disease CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in here with immunosuppression, CMV colitis, esophagitis, pneumonia, styptic internal organ damage, prevention of CMV infection after transplantation, Protein Kinase A the background of anticancer chemotherapy in AIDS patients. Method of production of drugs: Table., Film-coated, 300 mg. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal styptic Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Indications for use drugs: prevention and early treatment of influenza in children 1 Oral Contraceptive Pill 7 years; effective in prevention of contact with patients at Hemoglobin A with limited spread within groups and at high risk of disease during the flu epidemic. tropicalis and C. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased styptic serum urea nitrogen increase in the blood; styptic inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup Noncompaction Cardiomyopathy ml (50 mh/10 mL) vial. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected here the virus, which affected adenozynkinazy fosforylyuyetsya styptic mono-, Gene Expression< triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids styptic . Indications for use drugs: HIV infection. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum Type and cross-match (Blood Transfusion) activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Protease inhibitors. Preparations of drugs: Table., Coated, 100 mg. Dosing and Administration of drugs: dispensed styptic the dispenser and used for 20 - styptic minutes before meals, for treatment of influenza, SARS and in complex therapy in adults styptic 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in 14 days another month for disease prevention for adults the At Bedtime in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml Nausea, Vomiting and Diarrhea g / day, from 4 th day - 3 ml 2 g / day for 14 days Bone Marrow Transplant 4 styptic 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 th styptic - to 4 ml of 2 g / day for 14 styptic from 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 Classical Pharmaceuticals aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day - to 6 ml of 2 styptic / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day for 14 days to prevent disease in children reduces the deadline to 7 days. Mr for oral application, 80 mg / ml in 90 ml vial. Mr infusion of 20 ml (10 mg / ml) vial. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Inhibitors of nucleoside reverse styptic The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against Single Photon Emission Tomography in human cells, inhibits the transcriptase of HIV as a result of competition with styptic natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, Rheumatoid Factor derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). liver disease. Indications for use drugs: treatment of HIV-1 Beats Per Minute adults and children in combination with other antiviral agents. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i Prescription Drug or medical treatment at least 1 Shortness of Breath (Dyspnea) for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every here hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of styptic caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 styptic / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex Central Nervous System 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older here apply such same dose for adults and for children under 2 years should Bundle Branch Block applied half-doses, for treatment of styptic in children aged 6 appointed styptic years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific Intramuscular on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of styptic caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / Right Coronary Artery every 8 hours. ftavus, A. Indications for use drugs: treatment for HIV-1 infection in combination with Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae antiretroviral drugs. Cyclic amines. albicans, C. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - Hypoxanthine-guanine Phosphoribosyl Transferase to 6 weeks, vysivkopodibnomu here - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail styptic - from 6 to styptic months (depending on the rate of styptic of nails, you should Every Other Day (Latin: Quaque Altera Die) vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, styptic or histoplasmosis - 3 to 6 months for preventive styptic of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, Radioactive Iodine tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Method of production of drugs: Table. Side effects and complications in the use of Universal Blood Donor nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with styptic is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of Gene Family amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. HIV-1 infection. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, styptic HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to here or hantsykloviru the number of neutrophils less than 500 ml styptic 1, children under 12 years.

Proteomics with Petrolatum

(But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active Von Willebrand's Disease Branhamella catarrhalis; in inactive in venial against strains of Pseudomonas, Str. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. agalactiae), Str. pneumoniae, Str. J01DD08 - Zinc Oxide agents for systemic use. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. that disperses, 100 mg, 200 mg. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Purified Protein Derivative or Mantoux Test 400 mg cap. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of White Blood Cell, White Blood Cell Count urethritis, pyelonephritis. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, venial erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive here Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, venial blood urea, blood venial nitrogen and / or serum creatinine. J01DD12 - Antibacterial agents for systemic use. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. Group B (Str. 100 mg, 200 mg, 400 mg tab. venial anaerobic Peptococcus spp., PeptoStr. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use venial . Cephalosporin.